Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Industry-Supported Event

Industry-Supported Symposium
General Topic: Industry-Supported Symposium

ITS6: Advances in SLE Management: Expert Perspectives on Targeting DORIS Remission and Emerging Clinical Data for a Novel Treatment

Sunday, October 26, 2025
5:30 PM - 7:30 PM Central Time
Location: Regency Ballroom AB, Hyatt Regency
CE: 0.00

Non-CME In Person

    Industry Presenter(s)

  • Michelle Petri, MD, MPH (she/her/hers)

    Johns Hopkins University School of Medicine
    Timonium, Maryland, United States

    Disclosure information not submitted.

  • Richard Furie, MD

    Chief of the Division of Rheumatology
    Northwell
    Manhasset, NY, United States

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits through ACR.
This session will not be recorded for on-demand.

Please join us for an expert-led session reviewing the latest treatment advancements in systemic lupus erythematosus (SLE). Faculty will contextualize the new 2025 ACR SLE treatment guidelines, highlight the importance of targeting remission, and reinforce the value of guideline-directed medical therapy. Enhance your clinical knowledge and learn from leading experts as they review emerging data for a novel biologic treatment option with a unique mechanism of action. Developed and offered by AstraZeneca. Not an official program of the ACR.